Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Coxsackievirus-B4 Infection of Human Primary Pancreatic Ductal Cell Cultures Results in Impairment of Differentiation into Insulin-Producing Cells.

Bertin A, Sane F, Gmyr V, Lobert D, Dechaumes A, Kerr-Conte J, Pattou F, Hober D.

Viruses. 2019 Jul 2;11(7). pii: E597. doi: 10.3390/v11070597.

2.

Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor.

Jaïdane H, Caloone D, Lobert PE, Sane F, Dardenne O, Naquet P, Gharbi J, Aouni M, Geenen V, Hober D.

J Virol. 2012 Oct;86(20):11151-62. Epub 2012 Aug 1.

3.

Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates.

Sane F, Caloone D, Gmyr V, Engelmann I, Belaich S, Kerr-Conte J, Pattou F, Desailloud R, Hober D.

Cell Mol Life Sci. 2013 Nov;70(21):4169-80. doi: 10.1007/s00018-013-1383-4. Epub 2013 Jun 18.

PMID:
23775130
4.

Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.

Elmastour F, Jaïdane H, Benkahla M, Aguech-Oueslati L, Sane F, Halouani A, Engelmann I, Bertin A, Mokni M, Gharbi J, Aouni M, Alidjinou EK, Hober D.

Virulence. 2017 Aug 18;8(6):908-923. doi: 10.1080/21505594.2016.1252018. Epub 2016 Oct 28.

5.

Immunoglobulin G-dependent enhancement of the infection with Coxsackievirus B4 in a murine system.

Elmastour F, Jaidane H, Aguech-Oueslati L, Benkahla MA, Aouni M, Gharbi J, Sane F, Hober D.

Virulence. 2016 Jul 3;7(5):527-35. doi: 10.1080/21505594.2016.1152442. Epub 2016 Mar 30.

6.

Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice Stools.

Aguech-Oueslati L, Jaidane H, Sane F, Jrad-Battikh N, Hamed SB, Hober D, Gharbi J.

Curr Microbiol. 2018 Jan;75(1):32-39. doi: 10.1007/s00284-017-1347-2. Epub 2017 Aug 30.

PMID:
28856411
7.

Coxsackievirus B4 infection of murine foetal thymus organ cultures.

Brilot F, Jaïdane H, Geenen V, Hober D.

J Med Virol. 2008 Apr;80(4):659-66. doi: 10.1002/jmv.21016. Erratum in: J Med Virol. 2008 Jun;80(6):1131.

8.

Antibodies enhance the infection of phorbol-ester-differentiated human monocyte-like cells with coxsackievirus B4.

Goffard A, Alidjinou EK, Sané F, Choteau L, Bouquillon C, Caloone D, Lobert PE, Hober D.

Microbes Infect. 2013 Jan;15(1):18-27. doi: 10.1016/j.micinf.2012.10.005. Epub 2012 Oct 26.

PMID:
23108316
10.

Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.

Nekoua MP, Bertin A, Sane F, Alidjinou EK, Lobert D, Trauet J, Hober C, Engelmann I, Moutairou K, Yessoufou A, Hober D.

Cell Mol Life Sci. 2019 Jun 6. doi: 10.1007/s00018-019-03168-4. [Epub ahead of print]

PMID:
31172216
11.

Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.

Alidjinou EK, Engelmann I, Bossu J, Villenet C, Figeac M, Romond MB, Sané F, Hober D.

Virulence. 2017 Oct 3;8(7):1229-1244. doi: 10.1080/21505594.2017.1284735. Epub 2017 Jan 23.

12.

Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo.

Benkahla MA, Alidjinou EK, Sane F, Desailloud R, Hober D.

Antiviral Res. 2018 Nov;159:130-133. doi: 10.1016/j.antiviral.2018.10.002. Epub 2018 Oct 2.

PMID:
30290197
13.

Prolonged viral RNA detection in the central nervous system of one-week-old Swiss albino mice following coxsackievirus B4 and echovirus 9 infection.

El Hiar R, Hober D, Jaidane H, Sané F, M'hadheb-Gharbi MB, Caloone D, Gharbi J, Aouni M.

Intervirology. 2012;55(6):435-41. doi: 10.1159/000335549. Epub 2012 Mar 6.

PMID:
22398876
14.

In vitro cultivation of human fetal pancreatic ductal stem cells and their differentiation into insulin-producing cells.

Yao ZX, Qin ML, Liu JJ, Chen XS, Zhou DS.

World J Gastroenterol. 2004 May 15;10(10):1452-6.

15.

Coxsackievirus B4 vertical transmission in a murine model.

Jaïdane H, Halouani A, Jmii H, Elmastour F, Mokni M, Aouni M.

Virol J. 2017 Jan 31;14(1):16. doi: 10.1186/s12985-017-0689-5.

16.

Neurogenic differentiation 1 directs differentiation of cytokeratin 19-positive human pancreatic nonendocrine cells into insulin-producing cells.

Shimoda M, Chen S, Noguchi H, Matsumoto S, Grayburn PA.

Transplant Proc. 2010 Jul-Aug;42(6):2071-4. doi: 10.1016/j.transproceed.2010.05.114.

PMID:
20692411
17.

Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.

Engelmann I, Alidjinou EK, Bertin A, Bossu J, Villenet C, Figeac M, Sane F, Hober D.

Cell Mol Life Sci. 2017 Oct;74(20):3851-3861. doi: 10.1007/s00018-017-2567-0. Epub 2017 Jun 10.

PMID:
28601984
18.

How Does Thymus Infection by Coxsackievirus Contribute to the Pathogenesis of Type 1 Diabetes?

Michaux H, Martens H, Jaïdane H, Halouani A, Hober D, Geenen V.

Front Immunol. 2015 Jun 30;6:338. doi: 10.3389/fimmu.2015.00338. eCollection 2015. Review.

19.

In vitro pancreas duodenal homeobox-1 enhances the differentiation of pancreatic ductal epithelial cells into insulin-producing cells.

Liu T, Wang CY, Yu F, Gou SM, Wu HS, Xiong JX, Zhou F.

World J Gastroenterol. 2007 Oct 21;13(39):5232-7.

20.

Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine.

Alidjinou EK, Sané F, Bertin A, Caloone D, Hober D.

Antiviral Res. 2015 Apr;116:51-4. doi: 10.1016/j.antiviral.2015.01.010. Epub 2015 Feb 2.

PMID:
25655448

Supplemental Content

Support Center